ClinicalTrials.govpublic full text
Ociperlimab With Tislelizumab and Chemotherapy in Participants With Untreated Metastatic Non-Small Cell Lung Cancer
locally advanced, unresectable, or metastatic nonsmall cell lung cancer (nsclc), nonsmall cell lung cancer, stage iiib, nonsmall cell lung cancer, stage iv, metastatic, lung cancer, non-squamous, ociperlimab, tislelizumab, anti-pd-1, bgb-a317, bgb-a1217, anti-tigit
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 840490
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.